Medical Research Council Harwell Mammalian Genetics Unit and Mary Lyon Center

Harwell, United Kingdom

Medical Research Council Harwell Mammalian Genetics Unit and Mary Lyon Center

Harwell, United Kingdom
SEARCH FILTERS
Time filter
Source Type

Santiago-Sim T.,Baylor College of Medicine | Burrage L.C.,Baylor College of Medicine | Burrage L.C.,Texas Childrens Hospital | Ebstein F.,Charité - Medical University of Berlin | And 45 more authors.
American Journal of Human Genetics | Year: 2017

Ubiquitination is a posttranslational modification that regulates many cellular processes including protein degradation, intracellular trafficking, cell signaling, and protein-protein interactions. Deubiquitinating enzymes (DUBs), which reverse the process of ubiquitination, are important regulators of the ubiquitin system. OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features. In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans. Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates. Our findings suggest a role for OTUD6B in proteasome function, establish that defective OTUD6B function underlies a multisystemic human disorder, and provide additional evidence for the emerging relationship between the ubiquitin system and human disease. © 2017 American Society of Human Genetics


Koscielny G.,European Bioinformatics Institute | Yaikhom G.,Medical Research Council Harwell Mammalian Genetics Unit and Mary Lyon Center | Iyer V.,Wellcome Trust Sanger Institute | Meehan T.F.,European Bioinformatics Institute | And 29 more authors.
Nucleic Acids Research | Year: 2014

The International Mouse Phenotyping Consortium (IMPC) web portal (http://www.mousephenotype.org) provides the biomedical community with a unified point of access to mutant mice and rich collection of related emerging and existing mouse phenotype data. IMPC mouse clinics worldwide follow rigorous highly structured and standardized protocols for the experimentation, collection and dissemination of data. Dedicated 'data wranglers' work with each phenotyping center to collate data and perform quality control of data. An automated statistical analysis pipeline has been developed to identify knockout strains with a significant change in the phenotype parameters. Annotation with biomedical ontologies allows biologists and clinicians to easily find mouse strains with phenotypic traits relevant to their research. Data integration with other resources will provide insights into mammalian gene function and human disease. As phenotype data become available for every gene in the mouse, the IMPC web portal will become an invaluable tool for researchers studying the genetic contributions of genes to human diseases. © 2013 The Author(s). Published by Oxford University Press.

Loading Medical Research Council Harwell Mammalian Genetics Unit and Mary Lyon Center collaborators
Loading Medical Research Council Harwell Mammalian Genetics Unit and Mary Lyon Center collaborators